Overview
The present invention relates to a novel cytotoxic pentacyclic cholestane type glycoside with C-3 glucoside moiety and a special linkage between C-24 to C-25, isolated from the stem bark of Crataeva nurvala and a method of isolation thereof. The cytotoxic glycoside possesses anti-proliferative and apoptosis inducing properties against a number of cancerous cells most preferably against cervical cancer and prostrate cancer cells